Captopril

Discontinued Product

Captopril (Cat. No. 4455) has been withdrawn from sale for commercial reasons.
Cat.No. 4455 - Captopril | C9H15NO3S | CAS No. 62571-86-2
Description: ACE inhibitor; also inhibits LTA4 hydrolase
Chemical Name: 1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline
Purity: ≥98% (HPLC)
Datasheet
Citations (1)
Reviews
Literature (1)

Biological Activity for Captopril

Captopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 0.022 μM). Also displays reversible, competitive inhibition of leukotriene A4 (LTA4) hydrolase. Identified as targeting human host proteins that interact with SARS-CoV-2.

Technical Data for Captopril

M. Wt 217.29
Formula C9H15NO3S
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 62571-86-2
PubChem ID 44093
InChI Key FAKRSMQSSFJEIM-RQJHMYQMSA-N
Smiles O=C([C@H](C)CS)N1[C@H](C(O)=O)CCC1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Captopril

Certificate of Analysis / Product Datasheet
Select another batch:

References for Captopril

References are publications that support the biological activity of the product.

Zhang et al (1996) Effects of early capt. treatment and its removal on plasma angiotensin converting enzyme (ACE) activity and arginine vasopressin in hypertensive rats (SHR) and normotensive rats (WKY). Clin.Exp.Hypertens. 18 201 PMID: 8869001

Orning et al (1991) Inhibition of leukotriene A4 hydrolase/aminopeptidase by capt. J.Biol.Chem. 266 16507 PMID: 1885582

Fujita and Yoshikawa (1999) LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology. 44 123 PMID: 10604535

Gordon et al A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. Nature 583 PMID: 32353859

View Related Products by Product Action

View all Angiotensin-Converting Enzyme Inhibitors

Keywords: Captopril, Captopril supplier, ACE, inhibitors, angiotensin-converting, enzyme, antihypertensives, LTA4, reversible, inhibits, peptidyl, dipeptidase, A, carboxycathepsin, COVID-19, SARS-CoV-2, severe, acute, respiratory, syndrome, Angiotensin-Converting, Enzyme, Aminopeptidases, Hydrolase, 4455, Tocris Bioscience

1 Citation for Captopril

Citations are publications that use Tocris products. Selected citations for Captopril include:

Gupta et al (2014) Opioid receptor function is regulated by post-endocytic peptide processing. J Biol Chem 289 19613 PMID: 24847082


Reviews for Captopril

There are currently no reviews for this product. Be the first to review Captopril and earn rewards!

Have you used Captopril?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cardiovascular Research Product Guide

Cardiovascular Research Product Guide

A collection of over 250 products for cardiovascular research, the guide includes research tools for the study of:

  • Hypertension
  • Thrombosis and Hemostasis
  • Atherosclerosis
  • Myocardial Infarction
  • Ischemia/Reperfusion Injury
  • Arrhythmias
  • Heart Failure